Study finds GLP-1 drugs like Ozempic may reduce heart attack and stroke risk while aiding weight loss

A new study has found that GLP-1 drugs, like Ozempic, can lower the risk of heart attack, stroke, and dementia while also reducing substance cravings. The research involved about 2 million veterans with diabetes and highlighted both benefits and risks. While these medications can help with weight loss and other health issues, they are also linked to side effects such as nausea, vomiting, and low blood sugar. Some users have reported severe gastrointestinal problems after taking the drugs. This study is the first to detail the full range of effects associated with GLP-1 medications. Researchers hope it will encourage further investigation into their impact on health.